As expected, the pulmonary levels of IL-1β, IL-6, and TNF-α were markedly increased in the ARDS model mice (Figure 2C); however, those levels significantly decreased after the mice were treated with miR-124-3p (Figure 2C). This evidence concerns the gene IL6 and acute respiratory distress syndrome.